Lymphangioleiomyomatosis (LAM)
5 clinical trials · Condition
◉ Watch Lymphangioleiomyomatosis (LAM)
| Record | Firm | Date |
|---|---|---|
| Glutamine PET Imaging in LAM (NCT04388371) | Vanderbilt University Medical Center | 2019-10-18 |
| COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC (NCT02484664) | Brigham and Women's Hospital | 2016-06-15 |
| Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) (NCT00790400) | Novartis Pharmaceuticals | 2009-04-01 |
Track Lymphangioleiomyomatosis (LAM) automatically
Every clearance here is in the API, with alerts when new ones post.